Latest Breaking News On - Cathy steiner - Page 2 : comparemela.com

Titan Medical Reports Voting Results From Annual and

TORONTO, June 09, 2022 (GLOBE NEWSWIRE) Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and.

North carolinaUnited statesChapel hillPaul catafordAnthonyj giovinazzoCaryg vanceCathy steinerHeatherl knightTitan medical incSpecial meetingWednesday juneTitan medicalToronto stock exchange tmdTitan medical

Titan Medical Reports Second Quarter 2021 Financial Results

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesNorth carolinaChapel hillPaul catafordHeather knightStephen lemieuxKristen galfettiTammy carreaRicardo estapeCathy steinerDavid mcnallyOppenheimer fall healthcare life sciences medtech summitTitan medical incRegulatory affairsCapital fundGood laboratory practice

EMU continues to provide free Covid-19 testing to students and faculty during the summer semester

EMU continues to provide free Covid-19 testing to students and faculty during the summer semester
easternecho.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from easternecho.com Daily Mail and Mail on Sunday newspapers.

James smithAnna bowlingKathleen inmanAbbott binaxnowCathy steinerStudent centerVault healthஜேம்ஸ் ஸ்மித்க்யாத்லீந் இந்மந்கேத்தி ஸ்டீனர்மாணவர் மையம்பெட்டக ஆரோக்கியம்

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.

United statesScott langilleJames bowenCathy steinerMoberg pharmaceuticalsVerity pharmaceuticalsSun pharmaceutical industries ltdCompany annual information formCipher pharmaceuticals incCipher pharmaceuticalsToronto stock exchangeVerity pharmaceuticals incBausch healthCraig mullNormal course issuer bidFinancial executive